Evidence map›Paper›PMID 26672962›Full record

ArticleEuropean clinical respiratory journal2015

Application of nitric oxide measurements in clinical conditions beyond asthma.

Andrei Malinovschi, Dora Ludviksdottir, Ellen Tufvesson, Giovanni Rolla, Leif Bjermer, Kjell Alving, Zuzana Diamant

Open access · goldAbstract read
In one paragraph

Article in European clinical respiratory journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Multimorbidity in asthma, association with allergy, inflammatory markers and symptom burden, results from the Swedish GAClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2021
    Article
  8. Interaction ofACS infectious diseases · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Andrei MalinovschiDepartment of Medical Sciences: Clinical Physiology, Uppsala University, Uppsala, Sweden; Andrei.Malinovschi@medsci.uu.se.
Dora LudviksdottirDepartment of Respiratory Medicine and Sleep, Landspitali University Hospital, Reykjavik, Iceland.
Ellen TufvessonDepartment of Respiratory Medicine and Allergology, Institute for Clinical Science, Lund University, Lund, Sweden.
Giovanni RollaDepartment of Medical Sciences, Allergology and Clinical Immunology, University of Torino, Torino, Italy.
Leif BjermerDepartment of Respiratory Medicine and Allergology, Institute for Clinical Science, Lund University, Lund, Sweden.
Kjell AlvingDepartment of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Zuzana DiamantDepartment of Respiratory Medicine and Allergology, Institute for Clinical Science, Lund University, Lund, Sweden.
Lund University · SEUppsala University · SENational University Hospital of Iceland · ISUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fractional exhaled nitric oxide (FeNO) is a convenient, non-invasive method for the assessment of active, mainly Th2-driven, airway inflammation, which is sensitive to treatment with standard anti-inflammatory therapy. Consequently, FeNO serves as a valued tool to aid diagnosis and monitoring in several asthma phenotypes. More recently, FeNO has been evaluated in several other respiratory, infectious, and/or immunological conditions. In this short review, we provide an overview of several clinical studies and discuss the status of potential applications of NO measurements in clinical conditions beyond asthma.

Indexed as

allergic rhinitisallograft rejectionsbronchopulmonary dysplasiaCOPDcystic fibrosisexhaled nitric oxidehepatopulmonary syndromepulmonary hypertensionrespiratory infectionsscleroderma

Identifiers

PMID26672962
PMCPMC4653314
OpenAlexW1880213764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.